NLC Health Impact Fund

NLC Health Impact Fund is the fourth fund of NLC Health Ventures, recognized as Europe's largest early-stage healthcare investor. Operating from Amsterdam, Netherlands, the fund started actively investing in 2023, building a diversified portfolio of 50+ early-stage healthcare companies, spanning pre-seed to Series A/B stages. Its focus areas include medtech, biotech, digital health, and green health across Europe and the US. NLC, established in 2014, has a proven track record of building and scaling over 100 ventures, aiming to commercialize innovative patents from world-renowned universities, hospitals, and corporates to address critical healthcare needs and generate financial returns. As a certified B Corp, the fund adheres to SFDR 9 impact standards, emphasizing both financial and societal impact.